CLASS II ONGOING Device recall · Reported 14 Jun 2023 · FDA Enforcement Report

DePuy Mitek Bioknotless Plus w/ OC-Indicated for use recalled

DePuy Mitek, Inc., a Johnson & Johnson is recalling DePuy Mitek Bioknotless Plus w/ OC-Indicated for use in soft tissue to bone fixation in, distributed nationwide in the US. The recall was initiated on 13 Apr 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 10886705002122 All lot numbers
Quantity recalled2372 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1679-2023
FDA event ID
92210
Recalling firm
DePuy Mitek, Inc., a Johnson & Johnson, Norwood, MA
Classification
Class II
Status
Ongoing
Recall initiated
13 Apr 2023
FDA classified
2 Jun 2023
Reported
14 Jun 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

13 Apr 2023Recall initiated by company
2 Jun 2023Classified by FDA+50 days
14 Jun 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS¿ Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken BIOKNOTLESS¿ Anchor inserter tip detected during surgery may require removal, potentially causing bone damage and longer surgery time

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated for use in soft tissue to bone fixation in association with adequate postoperative immobilization Model Number: 212726

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Switzerland, China, Czech Republic, Germany, Egypt, Spain, United Kingdom, Hong Kong, Hungary, Ireland, India, Italy, Korea, Netherlands, New Zealand, Slovakia, Thailand.

Nationwide

Stores named: Walmart

Questions about this recall

Is DePuy Mitek Bioknotless Plus w/ OC-Indicated for use in soft tissue to bone fixation in recalled?

Yes. DePuy Mitek, Inc., a Johnson & Johnson recalled DePuy Mitek Bioknotless Plus w/ OC-Indicated for use in soft tissue to bone fixation in on 13 Apr 2023. The recall is Class II and its status is Ongoing. Recall number Z-1679-2023.

Why was it recalled?

IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS¿ Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken BIOKNOTLESS¿ Anchor inserter tip detected during surgery may require removal, potentially causing bone damage and longer surgery time

Which lots are affected?

UDI-DI: 10886705002122 All lot numbers

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Switzerland, China, Czech Republic, Germany, Egypt, Spain, United Kingdom, Hong Kong, Hungary, Ireland, India, Italy, Korea, Netherlands, New Zealand, Slovakia, Thailand.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DePuy Mitek, Inc., a Johnson & Johnson

All 51

Other Other Medical Devices recalls

All 13,778